Publication | Closed Access

Treatment Efficacy Score—continuous residual cancer burden-based metric to compare neoadjuvant chemotherapy efficacy between randomized trial arms in breast cancer trials

Breast OncologyOncologyTrial ArmsCancer ManagementClinical TrialsBreast CancerCancer TreatmentBreast Cancer TrialsNeoadjuvant Chemotherapy EfficacyMedicineRadiation OncologyHealth Sciences